COVID-19 vaccine trials for children is being rapidly conducted in the country ahead of the speculated third wave of infection. The trial of Bharat Biotech’s Covaxin on children is underway and results are expected by September, as informed by news agency ANI quoting Dr Randeep Guleria, Director of AIIMS Delhi. If the results come out positive, then the vaccine for children will be available by September. The second dose of Covaxin is likely to be administered to children aged 2-6 years next week, while the second dose of Covaxin has already been administered to children in the age group of 6-12 years at trials being conducted at AIIMS, Delhi.
Know more: ANI Twitter